Ahtna Corporation
Copper mining, rare mineral extraction, superconductor manufacturing, geothermal energy, materials science
Arcturus Defense Solutions
Private military contracting, weapons manufacturing, autonomous systems, BCI (military and consumer), corporate security services
Aleut Corporation
Pacific maritime resource management, deep-sea mineral extraction, fishery engineering, ocean thermal energy conversion, submarine cable networks, weather modification systems
Arctic Slope Regional Corporation
Petroleum extraction, hydrogen fuel production, carbon sequestration, Arctic engineering, permafrost infrastructure, energy storage systems, defense contracting
Ashford Signal
Electronic Warfare / Spectrum Management
Bathysphere Networks
Subsurface & Underwater Infrastructure, Deep Telecom & Lakebed Resource Extraction
Ashgrave Materials
Advanced Materials Science, Industrial Chemistry & Synthetic Resource Production
Calista Corporation
Freshwater resource management, water purification technology, permafrost hydrology, atmospheric water generation, wetland carbon credits, tundra agriculture
Bering Straits Native Corporation
Arctic shipping lane control, port operations, icebreaking services, maritime toll collection, cold-weather logistics, strategic minerals (gold, graphite), aquaculture
Bristol Bay Native Corporation
Engineered fisheries, aquaculture biotechnology, marine protein production, nutritional genomics, cold-water pharmaceutical extraction, freshwater management
Carrion Defense Works
Defense Manufacturing & Autonomous Weapons Systems
Charnel Propulsion
Advanced Propulsion & Aerospace Engineering
Chugach Alaska Corporation
Pipeline terminus operations, oil-to-hydrogen conversion, LNG transshipment, deep-water port management, glacier freshwater harvesting, maritime repair and refitting, energy logistics
Cinderblock Ai
Artificial Intelligence & Cognitive Infrastructure
Cinderfall Energy
Energy / Geothermal & Industrial Heat Recapture
Cook Inlet Region, Inc.
Financial services, banking, real estate, telecommunications, data centers, BCI interface manufacturing (licensed), healthcare, tourism, diplomatic services, inter-tribal commerce
Copperveil Intelligence
Predictive Analytics / Civilian Surveillance Infrastructure
Crestfall Aquaculture
Aquaculture / Protein Synthesis
Cormorant Naval Systems
Maritime Defense & Aquatic Infrastructure
Crucible Genomics
Applied Genomics, Designer Organism Agriculture & Labor Biology
Emberlace Systems
Smart Infrastructure & Adaptive Urban Systems
Dredge Mining Collective
Deep Mining, Lakebed Extraction & Rare Earth Recovery
Doyon, Limited
Rare earth element mining, critical mineral extraction, semiconductor materials, military-grade electronics supply, geothermal energy, timber, wilderness tourism, land management
Ferrogate Transit
Hypervelocity Ground Transit & Freight Rail Infrastructure
Helix Biosystems
Biotechnology, pharmaceuticals, gene editing, organ bioprinting, life extension, designer genetics
Gravemoss Biofoundry
Synthetic Biology / Industrial Fermentation
Ironclad Agrisystems
Autonomous agriculture, autonomous defense platforms, agricultural AI, food commodity production, territorial denial systems
Kelpline Logistics
Logistics & Intermodal Transport
Irontide Tidal Energy
Renewable Energy — Freshwater Tidal & Kinetic Generation
Lacuna Genomics
Biotech / Genetic Architecture
Koniag, Incorporated
Arctic shipping logistics, cold-chain warehousing, fisheries, transshipment port operations, maritime insurance, vessel certification, Arctic weather forecasting services
Mirrorwell Media
Media / Immersive Broadcast & Cognitive Advertising
Marrowvault Cryogenics
Cryogenic Preservation / Life Extension / Estate Management
Lazarus Pharmaceuticals
Pharmaceutical Manufacturing, Biological Dependency Engineering, & Medical Infrastructure
Novafold Pharmaceuticals
Pharmaceutical Sciences & Proteome Engineering
Nana Regional Corporation
Zinc mining, lead extraction, germanium production, advanced metallurgy, Arctic construction engineering, renewable energy systems, industrial-grade 3D printing feedstock
Nightshade Pharmatech
Pharmaceutical Manufacturing, Cognitive Enhancement & Neurochemical Services
Ouroboros Energy
Energy Generation, Grid Infrastructure, & Power Sovereignty
Oracle Drift Systems
Predictive Analytics / Intelligence Services / Algorithmic Governance
Pale Lantern Bioethics
Regulatory Compliance, Bioethics Certification & Corporate Audit Services
Pelican Drift Aquatics
Freshwater Resource Extraction / Desalination Technology
Pellucid Systems
Surveillance Technology, Data Brokerage & Predictive Intelligence
Palladian Construction
Megastructure Construction, Urban Demolition, & Territorial Reclamation
Ringo Corponation
Fuel, retail, transit, broadband, pharmacy, infrastructure, financial services, residential management
Rendstone Nuclear
Nuclear Energy / Fission Reactor Operations
Rictus Entertainment
Entertainment / Immersive Experience / Neural Recreation
Scoria Works
Heavy Industrial Fabrication & Structural Manufacturing
Sealaska Corporation
Sustainable timber, engineered wood products, carbon credits, tourism, cultural heritage management, cruise ship port operations, wilderness recreation, traditional art and craft export, hydroelectric power
Saltmarsh Telecom
Telecommunications & Signal Infrastructure
Slagworks Industrial
Heavy Manufacturing / Industrial Fabrication / Reclamation Metallurgy
Sulfur Crown Agriculture
Industrial Agriculture, Soil Remediation & Terraforming
Stonepath Logistics
Logistics / Heavy Transit & Sovereign Infrastructure Leasing
Silkworm Data
Data Brokerage & Predictive Analytics
Tessera Corponation
Brain-computer interfaces, neural technology, cognitive services, behavioral data markets, neural advertising
Thornback Agrichemical
Agrichemical Manufacturing, Soil Remediation & Controlled-Environment Agriculture
The Thirteenth Corporation
Global intelligence and information brokering, trade facilitation, diaspora financial services, diplomatic representation, cultural preservation (global), legal advocacy, counter-espionage, logistics coordination
Vellichor Institute
Neurotechnology & Memory Engineering
Verdant Systems
Environmental Engineering / Atmospheric Management & Carbon Architecture
Vantablack Media
Media, Propaganda, & Psychological Infrastructure
Tollgate Systems
Critical Infrastructure Ownership & Access Monetization
Zheng-dao Bioelectric
AI systems, data harvesting, neural mesh networks, cloud cognitive services, brain-computer interfaces, behavioral prediction
Vespid Dynamics
Autonomous Drone Logistics & Swarm Defense
Waxwing Neuromedia
Direct Neural Entertainment & Cognitive Advertising
Liang-Petrova Consortium
Fusion reactor manufacturing, heavy industrial engineering, orbital construction, asteroid mining, deep-space probe systems
Meridian Orbital Dynamics
Space infrastructure, orbital logistics, carbon nanotube manufacturing, asteroid mining support, counterweight station operations
Tessera Corponation
| number | 1 |
| name | Tessera Corponation |
| full legal name | Tessera CorpoNation Holdings, Ltd. (Sovereign Charter Entity, Austin Sovereign Zone) |
| common names |
|
| stock designation | TSRA (Tessera Behavioral Exchange, internal) |
| sector | Brain-computer interfaces, neural technology, cognitive services, behavioral data markets, neural advertising |
| valuation | Φ14.2 trillion |
| revenue | Φ1.89 trillion |
| employees | 4.1 million |
| sovereign territory | 18 chartered zones across 11 countries, totaling approximately 4,200 square kilometers |
| founding story | Tessera did not begin as Tessera. It began as NeuraLink Systems, Inc., a 2133 reorganization of the original Cortex Dynamics Corp after Aldric Vance's departure from the company in 2131 amid the broader collapse of his business empire. The regulatory enforcement actions against Vance Automotive, the social platform's insolvency proceedings, and the Frontier Launch nationalization crisis left Cortex Dynamics orphaned -- a genuinely promising neural interface company suddenly without its patron billionaire's funding pipeline or media amplification. What Cortex Dynamics had was talent. The engineering team that had achieved the first fully automated BCI surgical procedure in 2130 -- 94-second insertion, outpatient, local anesthetic -- was the most capable neural interface development group on Earth. They also had 1,400 patients with functioning N1 implants, a dataset of unprecedented depth in human neural signal processing, and a patent portfolio that would take any competitor fifteen years to work around. Dr. Amara Osei, Cortex Dynamics' Chief Neural Architect, led the management buyout in 2133. She brought in Vikram Chandra, a former McKinsey partner who had run the firm's healthcare M&A practice, as CEO. Chandra's first act was to rename the company Tessera -- from the Latin word for the small tiles in a mosaic, reflecting his stated vision that individual neural connections were tiles in a larger picture of human cognition. The name was elegant, the metaphor was apt, and Chandra meant every word of it. He genuinely believed that neural augmentation would complete the human mind the way a final tile completes a mosaic. This belief would become Tessera's greatest strength and its most dangerous blind spot. The 2134 Series C funding round brought in Φ4.8 billion from a consortium led by Sequoia Capital's successor fund, SoftBank Vision's remnant entities, and -- critically -- the sovereign wealth fund of the United Arab Emirates, which was already positioning itself for the post-oil economy. The UAE investment came with territorial concessions: Tessera received a 50-year charter to operate a "cognitive technology development zone" in Abu Dhabi, the first instance of a national government granting a neural interface company anything resembling sovereign operational authority. Chandra saw the template. He spent the next decade acquiring it everywhere he could. |
| relationship to big 20 | Tessera holds a 12% equity stake in Tethys Orbital Industries and is the exclusive supplier of neural interface technology for orbital personnel. Every climber pilot, tether maintenance worker, and station engineer carries Tessera hardware. The NovaMind Orbital variant is specifically calibrated for microgravity cognitive performance and is the only BCI certified for use above 400 kilometers altitude. Tessera also operates a pharmaceutical research module on Tethys Station Beta, where microgravity biocompatibility coatings for BCI electrodes are manufactured. This makes Tessera a critical node in the elevator's supply chain -- and gives Tessera leverage over Tethys that no equity stake alone could provide. Tessera's interest in the elevator is also territorial. The Tethys Articles of Elevation grant Tessera "preferred cognitive services provider" status across all orbital stations -- a soft monopoly on neural technology in space that mirrors its hard monopoly on Earth. --- |
| full text | ## 1. TESSERA CORPONATION **Full Legal Name:** Tessera CorpoNation Holdings, Ltd. (Sovereign Charter Entity, Austin Sovereign Zone) **Common Names:** Tessera, TessCorp (informal), "The Cathedral" (internal culture), "The Mind" (street slang) **Stock Designation:** TSRA (Tessera Behavioral Exchange, internal) **Sector:** Brain-computer interfaces, neural technology, cognitive services, behavioral data markets, neural advertising **Estimated Valuation (2198):** Φ14.2 trillion **Annual Revenue (2197):** Φ1.89 trillion **Total Employees (including indentures):** 4.1 million **Sovereign Territory:** 18 chartered zones across 11 countries, totaling approximately 4,200 square kilometers ### Founding Story Tessera did not begin as Tessera. It began as NeuraLink Systems, Inc., a 2133 reorganization of the original Cortex Dynamics Corp after Aldric Vance's departure from the company in 2131 amid the broader collapse of his business empire. The regulatory enforcement actions against Vance Automotive, the social platform's insolvency proceedings, and the Frontier Launch nationalization crisis left Cortex Dynamics orphaned -- a genuinely promising neural interface company suddenly without its patron billionaire's funding pipeline or media amplification. What Cortex Dynamics had was talent. The engineering team that had achieved the first fully automated BCI surgical procedure in 2130 -- 94-second insertion, outpatient, local anesthetic -- was the most capable neural interface development group on Earth. They also had 1,400 patients with functioning N1 implants, a dataset of unprecedented depth in human neural signal processing, and a patent portfolio that would take any competitor fifteen years to work around. Dr. Amara Osei, Cortex Dynamics' Chief Neural Architect, led the management buyout in 2133. She brought in Vikram Chandra, a former McKinsey partner who had run the firm's healthcare M&A practice, as CEO. Chandra's first act was to rename the company Tessera -- from the Latin word for the small tiles in a mosaic, reflecting his stated vision that individual neural connections were tiles in a larger picture of human cognition. The name was elegant, the metaphor was apt, and Chandra meant every word of it. He genuinely believed that neural augmentation would complete the human mind the way a final tile completes a mosaic. This belief would become Tessera's greatest strength and its most dangerous blind spot. The 2134 Series C funding round brought in Φ4.8 billion from a consortium led by Sequoia Capital's successor fund, SoftBank Vision's remnant entities, and -- critically -- the sovereign wealth fund of the United Arab Emirates, which was already positioning itself for the post-oil economy. The UAE investment came with territorial concessions: Tessera received a 50-year charter to operate a "cognitive technology development zone" in Abu Dhabi, the first instance of a national government granting a neural interface company anything resembling sovereign operational authority. Chandra saw the template. He spent the next decade acquiring it everywhere he could. ### Key Historical Milestones **2133 -- Founding.** Management buyout of NeuraLink Systems. Renamed Tessera. Dr. Amara Osei as Chief Neural Architect, Vikram Chandra as CEO. **2135 -- Abu Dhabi Charter.** First sovereign operational territory. Tessera establishes the Cognitive Development Zone, a 120-square-kilometer research and manufacturing campus exempt from UAE labor law, medical device regulation, and data privacy requirements. **2138 -- NovaMind Launch.** The first consumer-marketed BCI. 4,096 electrodes. Positioned as a "cognitive wellness platform." Initial price: Φ340,000 installed, Φ2,400/month subscription. Adoption by corporate executives, athletes, financial traders. Revenue doubles within eighteen months. The NovaMind is not the best BCI on the market in terms of raw electrode count -- Zheng-Dao's CortexLink will surpass it within three years -- but it is the most refined user experience. Tessera understood from the beginning that the interface was the product, not the electrode. **2141-2143 -- The Acquisition Sprint.** Tessera acquires seventeen companies in 30 months: VascuLink (the Stentrode vascular BCI), ParaNeural (high-bandwidth cortical interfaces), Kernel (non-invasive neural imaging), and fourteen smaller firms holding critical patents in neural signal processing, biocompatible electrode materials, and surgical robotics. The acquisitions are funded by revenue from the NovaMind line and a Φ22 billion bond issuance underwritten by JPMorgan's successor entity. By the end of 2143, Tessera holds approximately 62% of all active neural interface patents worldwide. **2144 -- The Cognition Tax Coalition.** Several surviving national governments attempt to classify BCIs as taxable cognitive enhancements. Tessera leads the Tessera-Zheng-Dao-Arcturus lobbying coalition, spending Φ4.2 billion in a single legislative cycle. The argument: BCIs are prosthetics, and taxing prosthetics is discriminatory. The tax dies. The coalition holds. It is the first major instance of BCI corponations cooperating against sovereign government authority -- and the template for every subsequent joint action. **2147 -- Austin Sovereign Zone Established.** The Texas state legislature, facing a Φ40 billion infrastructure deficit, ratifies the Austin Sovereign Zone Charter. Tessera receives proprietary jurisdiction over 800 square kilometers of central Texas, including the former city of Austin, in exchange for Φ90 billion in infrastructure investment, job guarantees, and a revenue-sharing arrangement that gives Texas 3% of Tessera's sovereign-zone economic output. Tessera moves its global headquarters from Palo Alto to the Austin campus. The Palo Alto facility is converted to a NovaMind surgical center. **2150 -- NeoCortex Industries Established.** Tessera creates NeoCortex Industries as a wholly owned subsidiary, ostensibly focused on "advanced neural development research." NeoCortex is organized as a separate legal entity with its own charter, its own security division, its own internal review board, and its own accounting. Its facilities are located within Tessera sovereign territory but operate under a separate access classification. Most Tessera employees do not have clearance to enter NeoCortex facilities. Most Tessera employees do not know what happens inside them. This is by design. NeoCortex is the wall between Tessera's genuine achievements and Tessera's human testing pipeline. **2155 -- The Employment Mandate.** Tessera makes the NovaMind IV a condition of employment for all salaried positions above Grade 7. Unaugmented employees cannot process information at the speed required by Tessera's neural-integrated workflow systems. Competitors follow within eighteen months. By 2158, 40% of corponation white-collar positions require a BCI. Tessera did not mandate augmentation to be cruel. They mandated it because their systems genuinely required it, and because they genuinely believed augmentation made people's lives better. The fact that it also made those people permanently dependent on Tessera's firmware was, in the internal narrative, an engineering constraint, not a business model. The business model was a consequence. Tessera tells itself. **2162-2168 -- Global Expansion.** Tessera establishes sovereign zones in Singapore, Mumbai, Lagos, Sao Paulo, London, and Seoul. Each follows the Austin template: infrastructure investment in exchange for proprietary jurisdiction. By 2168, Tessera operates on every inhabited continent and has more sovereign territory than forty-three recognized nation-states. **2171 -- Chandra Steps Down.** Vikram Chandra retires as CEO, citing health reasons. He is 74. His Tier 3 cognitive augmentation has been operational for nineteen years. He moves to Station Omega on the space elevator, where he maintains an advisory role and a viewport apartment. His successor is Dr. Lena Vasquez, a twenty-year Tessera veteran who rose through the NovaMind product division. Vasquez is a true believer in augmentation -- her personal implant is Tier 3, one of the earliest civilian installations. She has never experienced adult life without cognitive enhancement. This shapes her leadership profoundly: she cannot imagine why anyone would choose to be unaugmented, which makes her genuinely compassionate toward those she believes she is helping and genuinely blind to the coercion embedded in how that help is delivered. **2189 -- The Meridian Disclosure.** A data breach -- believed to be the work of a NeoCortex security officer who went ghost -- releases 14,000 pages of internal NeoCortex Industries documentation into the public domain. The documents detail the Neural Development Program: non-consensual human testing on subjects sourced from homeless populations, climate refugees, and prisoners. The documents describe five stages of the pipeline -- Acquisition, Processing, Implantation, Data Extraction, and Disposition -- including the R-3 "Terminal Disposition" category, which is never defined in the documents but whose meaning is unmistakable from context. The leak is the largest single exposure of corponation human testing practices in history. Tessera's response is swift and disciplined. Vasquez issues a public statement expressing "deep concern" and announcing an internal investigation. The investigation, conducted by Tessera's own legal division, concludes that NeoCortex Industries operated "outside the boundaries of Tessera's ethical framework" and that "certain personnel exceeded their authorized research parameters." Fourteen NeoCortex employees are terminated. Two are referred to Tessera's Internal Adjudication Tribunal. None face external prosecution, because no external authority has jurisdiction over Tessera sovereign territory. NeoCortex Industries is not shut down. It is "restructured." The Neural Development Program continues under revised operational security protocols. The primary change: better document control. **2193 -- Behavioral Exchange Launch.** Tessera launches the Tessera Behavioral Exchange (TBX), a formal trading platform for neural data derivatives. Daily volume reaches Φ2.3 billion within eighteen months. The TBX trades prediction products derived from NovaMind user data -- behavioral futures that allow advertisers, employers, insurers, and security agencies to bid on predictive access to specific individuals or populations. The TBX makes Tessera's data harvesting operation not merely profitable but foundational to the global financial system. Dismantling it would now require dismantling the economy that depends on it. ### Territory and Sovereign Holdings Tessera's sovereign territory spans eighteen chartered zones: - **Austin Sovereign Zone (primary)** -- 800 sq km, central Texas. Global headquarters. Population: 2.1 million. - **Abu Dhabi Cognitive Zone** -- 120 sq km. Original charter territory. R&D focus. - **Singapore Neural Campus** -- 45 sq km. Asia-Pacific operations hub. - **Mumbai Innovation Zone** -- 200 sq km. Manufacturing and South Asian operations. - **Lagos Tessera District** -- 160 sq km. African operations. Fastest-growing zone. - **13 additional zones** across South America, Europe, East Asia, and Oceania, ranging from 20 to 400 sq km. Total sovereign population across all zones: approximately 12.8 million people living under Tessera proprietary jurisdiction. ### Security Force: Tessera Sovereign Security (TSS) **Total Personnel:** 68,000 **Structure:** Three-tier model mirroring the Ringo template. - **Tier 1 -- Facility Security ("Whites"):** 42,000 personnel. Uniformed guards at Tessera campuses, surgical centers, retail locations, and residential zones. Lightly armed. Primary function is visible deterrence and biometric screening. Named for their white-and-silver uniforms, which Tessera's branding division designed to evoke medical authority rather than military force. The effect is intentional: Tessera wants its security to feel like healthcare, not occupation. - **Tier 2 -- Rapid Response ("Prisms"):** 18,000 personnel. Mobile units deployed for incidents beyond Tier 1 capacity. Equipped with exoskeletal armor, squad-level drone support, and neural disruption countermeasures. Prisms are notable for carrying defensive neural weaponry -- they can project localized EMPs calibrated to disrupt hostile BCI activity without affecting Tessera-firmware implants, which carry a proprietary hardening protocol. - **Tier 3 -- Strategic Operations ("Veil"):** Estimated 8,000 personnel. Tessera does not acknowledge Veil's existence. Intelligence gathering, corporate espionage interdiction, high-value asset protection, and -- per the Meridian Disclosure documents -- security operations for NeoCortex Industries facilities, including subject acquisition for the Neural Development Program. ### Leadership Structure **CEO:** Dr. Lena Vasquez (age 62, Tier 3 augmented, in role since 2171). A genuine visionary with genuine blind spots. Vasquez believes augmentation is the next step in human evolution. She runs Tessera with missionary conviction. Her annual address to employees is called "The Mosaic" and is delivered as a neural-broadcast experience -- a shared cognitive event that reinforces Tessera's founding narrative. Employees describe it as transcendent. Critics describe it as corporate indoctrination delivered directly to the brain. **Chief Neural Architect:** Dr. Kwame Asante (age 48, Tier 3 augmented). Head of all BCI R&D. Asante is the closest thing Tessera has to a conscience in the C-suite. He designed the NovaMind V's improved biocompatibility protocols, which reduced long-term neural scarring by 60%. He has petitioned twice to be given oversight of NeoCortex Industries. He has been denied twice. He remains at Tessera because he believes he does more good inside than he could outside. He may be right. He may be telling himself a story. **Chief Revenue Officer:** Marcus Wei (age 55, Tier 3 augmented). Architect of the Tessera Behavioral Exchange and the CogAd neural advertising platform. Wei is a pure monetization strategist. He does not share Vasquez's missionary fervor -- he views augmentation as a platform and humans as a user base. The tension between Wei's revenue optimization agenda and Vasquez's "augmentation as human flourishing" narrative is the central fault line of Tessera's executive culture. **Director, NeoCortex Industries:** Dr. Elise Seo (age 59, Tier 3 augmented). The most powerful person at Tessera that most Tessera employees have never heard of. Seo runs the human testing pipeline. Her public title is "Chief Research Ethics Compliance Officer," a designation so Orwellian that it would be funny if the consequences were not measured in human lives. Seo is not a sadist. She is a utilitarian who has calculated that the suffering of test subjects is justified by the millions of lives improved by the consumer products those subjects' data made possible. She sleeps well. This is the most disturbing thing about her. **Board of Directors:** Twelve members, including representatives from the UAE sovereign wealth fund (2 seats), institutional investors (4 seats), Tessera founding family trusts (2 seats, including Dr. Osei's descendants), and independent directors (4 seats, though "independent" means "chosen by the CEO"). The board's primary function is capital allocation and strategic oversight. They do not involve themselves in NeoCortex operations. They do not ask about NeoCortex operations. They have structured their governance to ensure they never need to. ### Internal Culture and Contradictions Tessera's internal culture is built on a genuine belief that cognitive augmentation is good for humanity. This is not cynical corporate messaging. The majority of Tessera's 4.1 million employees sincerely believe they are making human life better. They point to real achievements: the NovaMind's memory augmentation has restored functional cognition to hundreds of thousands of dementia patients. Tessera's neural rehabilitation protocols have given mobility back to paralysis patients. The cognitive enhancement packages have allowed human minds to solve problems -- in medicine, engineering, climate science -- that unaugmented cognition could not. These achievements are real. They are not fabricated. They are not propaganda. They are the reason good people work at Tessera and stay at Tessera and defend Tessera. The contradiction is NeoCortex Industries. The compartmentalization is so complete that the vast majority of Tessera employees -- including most of the executive team -- genuinely do not know the details of the human testing pipeline. They know NeoCortex exists. They know it does "advanced research." They do not know about the Voluntary Contribution Program, the Neural Development Candidates, the R-3 dispositions. The Meridian Disclosure put the documents in front of the world, and Tessera's internal narrative absorbed it the way any institutional culture absorbs inconvenient truth: by isolating the problem ("those were rogue employees"), affirming the mission ("our work saves lives"), and moving forward. The documents are publicly available. Most Tessera employees have not read them. Not because they are forbidden. Because they do not want to. The second contradiction is economic. Tessera's Terms of Cognitive Service assign ownership of all neural data generated by NovaMind implants to Tessera in perpetuity. Users who understood the implications would refuse the terms. Users are presented with the terms during the pre-surgical sedation window. This is not an accident. The cognitive advertising system -- CogAd -- inserts brand associations directly into users' cognitive streams, indistinguishable from the user's own thoughts. Tessera's missionary culture frames this as "cognitive commerce," a natural extension of the augmented mind's engagement with the world. The street frames it as "head spam." Both are accurate. The third contradiction is dependency. Tessera's subscription model -- from NovaMind Basic at Φ180/month to NovaMind Apex at Φ4,800/month -- creates a dependency structure so total that the threat of service interruption is more coercive than any physical force. The Graduated Service Reduction protocol strips cognitive capabilities over a 30-day timeline, culminating in implant dormancy. For long-term users, this is not inconvenience. It is cognitive mutilation. Tessera knows this. Tessera's retention rates reflect this. ### What They Do Well - **Consumer BCI quality.** The NovaMind line is the gold standard. Superior user experience, lower complication rates, better long-term biocompatibility than any competitor. If you are going to have a corporate implant in your brain, you want it to be a Tessera. - **Neural rehabilitation.** Tessera's medical division has restored cognitive function to over 600,000 dementia patients, returned mobility to 200,000+ paralysis patients, and developed speech restoration protocols used in hospitals worldwide. - **Cognitive accessibility.** The NovaMind Basic tier, at Φ180/month, is the most affordable path to functional augmentation in the formal economy. It is not cheap. It is cheaper than the alternative: unemployment in a world where unaugmented humans are functionally unemployable. - **Research output.** Tessera's neural science publications (through its legitimate research divisions) account for approximately 40% of all peer-reviewed BCI research. Their open-source neural signal processing libraries are used by every competitor and most academic institutions. ### What They Do Terribly - **Human testing.** NeoCortex Industries has processed an estimated 200,000-300,000 non-consensual test subjects since 2150. The R-3 Terminal Disposition category has never been publicly defined. - **Cognitive harvesting.** Every thought, dream, fear, and desire generated by a NovaMind user is recorded, analyzed, and sold on the Tessera Behavioral Exchange. Users cannot opt out. They agreed to this during sedation. - **Subscription coercion.** The Graduated Service Reduction protocol weaponizes neurological dependency. People will accept any contract, any indenture term, any data harvesting agreement to avoid cognitive withdrawal. Tessera designed it this way. - **Neural advertising.** CogAd insertions at the Basic tier run 8-12 per hour. Users on Basic cannot distinguish their own desires from inserted ones. The technology is, by any honest description, a form of non-consensual cognitive manipulation at industrial scale. ### Relationship to the Space Elevator Tessera holds a 12% equity stake in Tethys Orbital Industries and is the exclusive supplier of neural interface technology for orbital personnel. Every climber pilot, tether maintenance worker, and station engineer carries Tessera hardware. The NovaMind Orbital variant is specifically calibrated for microgravity cognitive performance and is the only BCI certified for use above 400 kilometers altitude. Tessera also operates a pharmaceutical research module on Tethys Station Beta, where microgravity biocompatibility coatings for BCI electrodes are manufactured. This makes Tessera a critical node in the elevator's supply chain -- and gives Tessera leverage over Tethys that no equity stake alone could provide. Tessera's interest in the elevator is also territorial. The Tethys Articles of Elevation grant Tessera "preferred cognitive services provider" status across all orbital stations -- a soft monopoly on neural technology in space that mirrors its hard monopoly on Earth. --- |